nitrazepam (Mogadon) Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Nitrazepam, sold under the brand name Mogadon among others, is a hypnotic drug of the benzodiazepine class used for short-term relief from severe, disabling anxiety and insomnia. It also has sedative (calming) properties, as well as amnestic, anticonvulsant, and skeletal muscle relaxant effects.   Wikipedia

Chemistry

  • SMILES: [O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3)c2c1
  • InChIKey: KJONHKAYOJNZEC-UHFFFAOYSA-N
  • Mol. Mass: 281.27
  • ALogP: 2.38
  • ChEMBL Molecule:
    nitrazepam  
More Chemistry

Pharmacology

Drug Pricing (per unit)

Australia

$0.0530
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

1,3-dihydro-7-nitro-5-phenyl-2h-1,4-benzodiazepin-2-one | 2,3-dihydro-7-nitro-5-phenyl-1h-1,4-benzodiazepin-2-one | 7-nitro-1,3-dihydro-5-phenyl-2h-1,4-benzodiazepin-2-one | 7-nitro-5-phenyl-2,3-dihydro-1h-1,4-benzodiazepin-2-one | apodorm | atempol | benzalin | calsmin | eatan | eunoctin | gerson | hipnax | hipsal | ibrovek | imeson | imesont | mogadon | n-desmethylnimetazepam | nelbon | nelmat | neozepam | neuchlonic | nitrados | nitrazadon | nitrazepam | nitrazepamum | nitrodiazepam | paxisyn | pelson | persopit | radedorm | relact | remnos | ro-45360 | ro-53059 | somitran | somnite | sonebon | sonnolin | trazenin | unisomnia

Organizations (16)

Research & Development (16)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (9)

Approved Indications (1)


 

Anxiety

Experimental Indications - Clinical Trial Phases 1-4 (9)


 

Anxiety ()

Anxiety Disorders (Phase 3)

Dementia (Phase 3)

Depression (Phase 3)

Epilepsy (Phase 4)

Psychophysiologic Disorders (Phase 3)

Schizophrenia (Phase 3)

Sleep Initiation and Maintenance Disorders (Phase 3)

Spasms, Infantile (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial Organizations: 16

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue